Form 4: Procter & Gamble Executive Moses Victor Javier Aguilar Reports Stock Option Grant and RSU Acquisition

Chief Research, Development & Innovation Officer of Procter & Gamble, Moses Victor Javier Aguilar, reports acquisition of restricted stock units and stock options.

Summary

• On October 1, 2024, Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer of Procter & Gamble, reported transactions involving Procter & Gamble common stock and stock options.
• Aguilar acquired 3,916 shares of common stock through Restricted Stock Units (RSUs) awarded under the company's 2019 Stock and Incentive Compensation Plan.
• Aguilar also acquired 18,623 stock options with an exercise price of $173.04, exercisable from October 1, 2027, and expiring on September 29, 2034.
• Following these transactions, Aguilar directly owns 24,934.7898 shares of common stock and 18,623 stock options.
• Aguilar also indirectly owns 6,117.2612 shares through a retirement plan trustee and 428.6033 shares through the International Stock Ownership Plan (Mexico) trustee.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and incentivized management structure. The sentiment is neutral to positive as it suggests alignment of interests between management and shareholders.

Positives

• The acquisition of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule of the stock options (exercisable from October 1, 2027) encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements, but the granting of stock options and RSUs suggests an ongoing commitment to incentivizing executive performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are common in publicly traded companies like Procter & Gamble to align management's interests with shareholder value.
• The specific terms of the stock options and RSUs (exercise price, vesting schedule) are likely determined based on industry benchmarks and company-specific performance goals.
• Comparing the size of the grant to similar roles at companies like Unilever or Nestle would provide further context.

Stakeholder Impact

• Shareholders may view the executive's increased stake in the company positively, as it aligns their interests.
• Employees may see the executive compensation package as a sign of the company's commitment to rewarding performance.

Key Dates